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Unfolded protein response (UPR) of the endoplasmic reticulum
(UPRER) helps maintain proteostasis in the cell. The ability to
mount an effective UPRER to external stress (iUPRER) decreases
with age and is linked to the pathophysiology of multiple age-
related disorders. Here, we show that a transient pharmacological
ER stress, imposed early in development on Caenorhabditis ele-
gans, enhances proteostasis, prevents iUPRER decline with age,
and increases adult life span. Importantly, dietary restriction
(DR), that has a conserved positive effect on life span, employs this
mechanism of ER hormesis for longevity assurance. We found that
only the IRE-1–XBP-1 branch of UPRER is required for the longevity
effects, resulting in increased ER-associated degradation (ERAD)
gene expression and degradation of ER resident proteins during
DR. Further, both ER hormesis and DR protect against polyglut-
amine aggregation in an IRE-1–dependent manner. We show that
the DR-specific FOXA transcription factor PHA-4 transcriptionally reg-
ulates the genes required for ER homeostasis and is required for ER
preconditioning-induced life span extension. Finally, we show that
ER hormesis improves proteostasis and viability in a mammalian cel-
lular model of neurodegenerative disease. Together, our study iden-
tifies a mechanism by which DR offers its benefits and opens the
possibility of using ER-targeted pharmacological interventions to
mimic the prolongevity effects of DR.
endoplasmic reticulum | dietary restriction | hormesis | life span | aging
Avast majority of the secreted as well as membrane proteinsfold and mature in the endoplasmic reticulum (ER) before
they are exported to their destinations (1). The protein folding
capacity of the ER is carefully monitored and calibrated by 3
conserved signal transducers, collectively called the unfolded
protein response (UPRER) regulators, that ensure protein
homeostasis (proteostasis) and proper cellular function. This is
achieved by activating the proteostasis network (PN) consisting
of molecular chaperons, protein degradation machinery, and stress
response pathways that act to resolve consequences of protein
misfolding in the ER (2). In metazoan ER, the 3 arms of UPRER,
namely IRE1, PERK, and ATF6, function in parallel to trigger
the PN and counteract ER stress by 1) increasing folding capacity
through the expression of various chaperons, 2) attenuating trans-
lation to reduce protein load in ER, 3) regulating IRE1-dependent
decay of mRNA (RIDD), or by 4) activating ER-associated pro-
teasomal degradation (ERAD) to remove terminally misfolded
proteins (3–5).
Aging is characterized by a catastrophic collapse of the pro-
teostasis network due to the loss of protein quality-control ma-
chineries across the cellular compartments (2, 6–8). With age,
the ER structure begins to deteriorate and the ER health fails as
it is unable to mount an optimal UPRER in response to external
stress (induced UPRER [iUPRER]) (6, 8–10). Expression levels of
key ER mRNA and proteins as well as activities of ER resident
proteins, including BiP, PDI, calnexin, and GRP94, are known to
decline with age (11–13). As a possible consequence, many diseases
of protein misfolding, including Alzheimer’s, Parkinson’s, and
Huntington’s diseases, are age-onset disorders.
The flagging cellular proteostasis can be improved simply by
exposing cells or organisms to moderate stress before they en-
counter any acute stress. This process is called hormesis and has
been shown to be beneficial to life span and health (14–16).
Hormesis can be affected in a compartment-specific manner in a
cell. For example, in Caenorhabditis elegans, Drosophila, and
human fibroblasts, hormetic heat shock up-regulates cytosolic
molecular chaperones that further protect against acute heat
stress (17–19). In C. elegans, glucose restriction increases mito-
chondrial respiration and reactive oxygen species (ROS) pro-
duction, which results in protection against oxidative stress and
enhanced longevity by a process termed mitohormesis (20).
Mitohormesis has also been implicated in other long-lived
mutants in worms (21, 22) and fly (23). Similarly, ER hormesis
has been observed in Drosophila carrying mutations associated
with ER protein folding/degradation machinery that induce cyto-
protective response toward subsequent ER insults (24, 25). In
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mammalian cells, ER stress preconditioning protects against
brain ischemia and attenuates heart ischemia/reperfusion injury
(26, 27). ER preconditioning is also neuroprotective in Dro-
sophila and mice models of Parkinson’s disease (28). Recently,
mutation in the C. elegans heterochromatin protein like-2 (HPL-2),
was shown to produce a hormetic induction of stress resistance
dependent on the IRE-1 branch of UPRER (29). Further, over-
expression of xbp-1s (the transcription factor otherwise induced in
response to ER stress) in neurons has been shown to increase
longevity in a cell nonautonomous manner (9), suggesting a possible
role of ER hormesis in life span regulation.
Dietary restriction (DR) is a conserved intervention that can
delay proteostasis, activate cytoprotective pathways, and increase
life span across species (30). It has been suggested that DR may
act as a mild stress that enhances life span through hormesis
(31). The fact that glucose restriction, that is akin to DR, in-
creases life span through mitohormesis attests to this (20).
However, the involvement of ER hormesis in DR is not known.
Here, using 2 genetic models of DR, we show that dietary re-
striction transiently up-regulates UPRER during early larval de-
velopment, possibly as a result of reduced protein glycosylation.
Mimicking this response with a pharmacological glycosylation
inhibitor, tunicamycin (Tm) or a nonhydrolyzable glucose analog
(2-deoxyglucose), increases life span. Both transient UPRER and
increased life span depend on the ER stress sensor, IRE-1. We
show that the transient ER stress leads to better iUPRER at
adulthood and better proteostasis. Consequently, ERAD genes
are up-regulated by DR, leading to efficient degradation of
ER resident proteins and thus contributes toward enhanced
proteostasis in adults and increased longevity. The DR-specific
FOXA transcription factor PHA-4 transcriptionally regulates
UPRER during early larval development as well as the increase in
ER protein processing genes during adulthood in DR worms,
justifying its central role in DR-associated longevity assurance.
Finally, we found that transient ER stress improves proteostasis
in C. elegans as well as in a mammalian cell culture model of
polyglutamine aggregation-induced proteotoxicity. Thus, our
study elucidates a mechanism by which DR positively affects life
span and shows that transient nutrient restriction or ER-directed
pharmacological intervention during development may be an
effective intervention to treat protein misfolding disorders as
well as increase life span.
Results
DR Triggers a Transient Up-Regulation of UPRER during Early Larval
Development. In order to elucidate the kinetics of UPRER during
nutrient stress, we evaluated the levels of UPRER in the 2 genetic
paradigms of DR, namely eat-2(ad1116) (32) and drl-1 RNAi
(33). For this, we used the Phsp-4:gfp(zcIs4) transgenic strain,
where the promoter of hsp-4 is transcriptionally fused to gfp and
GFP fluorescence gives a quantitative readout of UPRER (34,
35). We compared the GFP fluorescence in Phsp-4:gfp(zcIs4)
and eat-2(ad1116);Phsp-4:gfp(zcIs4) at 32 to 35 h after eggs were
placed on the plates (egg synchronization) and found that DR
triggered a transient up-regulation of UPRER specifically during
the L2 larval stage of eat-2(ad1116) (Fig. 1A). The transient up-
regulation was observed irrespective of the way the eggs were
obtained, either by bleaching or by synchronized egg lay of gravid
adult worms (SI Appendix, Fig. S1A). The basal UPRER was
found to be the same in WT or DR worms in other larval stages,
suggesting that only an early-life transient up-regulation of UPRER
is specific to conditions that mimic DR (Fig. 1B). Likewise, we grew
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Fig. 1. DR triggers a transient up-regulation of UPRER early in life. (A) Representative images of transient UPRER of Phsp-4:gfp(zcIs4) and eat-2(ad1116);Phsp-
4:gfp(zcIs4) worms at L2 (32 h after egg synchronization) grown on control, ire-1, or xbp-1 RNAi. Densitometric quantification shows the up-regulation of
UPRER on control RNAi but not on ire-1 and xbp-1 RNAi. Average of 2 biological replicates is shown. Error bars show SD. *P < 0.05 by 2-way ANOVA. (B)
Representative images of Phsp-4:gfp(zcIs4) and eat-2(ad1116);Phsp-4:gfp(zcIs4) at indicated larval stages and in gravid adults. Densitometric quantification
shows no up-regulation in basal UPRER in these stages in eat-2(ad1116) compared to WT. Basal UPRER is down-regulated in eat-2(ad1116) in gravid adults.
Average of 2 biological replicates is shown. Error bars show SD. *P < 0.05 by Student’s t test. YA, young adult. (C) Representative images of transient UPRER of
Phsp-4:gfp(zcIs4) and eat-2(ad1116);Phsp-4:gfp(zcIs4) L2 stage worms grown in presence or absence of 2% glucose. The transient UPRER is suppressed in
presence of glucose in eat-2(ad1116);Phsp-4:gfp(zcIs4). Average of 3 biological replicates is shown. Error bars show SD. *P < 0.05 by 2-way ANOVA. ns,
nonsignificant. (D) Concavalin A Western analysis of WT or eat-2(ad1116) with or without 2% glucose supplementation. WT has more glycosylated proteins
compared to eat-2(ad1116). Glucose supplementation increases the levels of glycosylated proteins. Quantified Western blot with different amounts of loaded
proteins is presented in SI Appendix, Fig. S2B.
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Phsp-4:gfp(zcIs4) on control or drl-1 RNAi and found that DR
implemented by drl-1 knockdown (KD) triggered a similar transient
up-regulation of UPRER specifically during the L2 larval stage (SI
Appendix, Fig. S1 B and C). Importantly, this response was found to
be ER specific as the cytosolic [Phsp-16.2:gfp(dvIs20)] or mitochon-
drial [Phsp-6:gfp(zcIs9)] stress response reporters were not affected (SI
Appendix, Fig. S1D). This early and transient up-regulation of the ER
stress response was found to be dependent on the IRE-1–XBP
branch of UPRER as eat-2(ad1116);Phsp-4:gfp(zcIs4) grown
on ire-1 or xbp-1 RNAi were unable to show similar response
(Fig. 1A). Also, ire-1(zc14);Phsp-4:gfp(zcIs4) worms grown on
drl-1 RNAi failed to mount the transient UPRER at L2 (SI Ap-
pendix, Fig. S1E). Further, 3 other ER resident proteins, ER
chaperons calnexin ortholog cnx-1 and enpl-1 as well as ER
oxido-reductin ortholog ero-1 are transcriptionally up-regulated
in eat-2(ad1116) (SI Appendix, Fig. S2A) with distinct temporal
kinetics. Together, an early and transiently high basal UPRER in
eat-2(ad1116) mutants and on drl-1 knockdown suggests higher
ER stress levels at initial larval life in worms undergoing a DR-
like condition since hatching.
DR may lead to depletion in the availability of glucose for
metabolism that may cause the observed up-regulation of basal
UPRER. If that is the case, supplementing glucose to worms un-
dergoing DR should suppress the transient UPRER up-regulation.
We used media supplemented with 2% glucose and grew the
Phsp-4:gfp(zcIs4) or eat-2(ad1116);Phsp-4:gfp(zcIs4) worms on
them. We observed that the transient UPRER up-regulation is
mitigated on glucose-containing media in eat-2(ad1116) (Fig.
1C), suggesting that glucose deprivation may cause the early ER
stress during DR. Glucose is essential for protein glycosylation
and hence ER proteostasis; depletion could decrease protein
glycosylation and increase ER stress. Consistent with this hy-
pothesis, we found that eat-2(ad1116) worms have lower levels of
protein glycosylation compared to WT, using a concavalin A
(ConA) Western assay (Fig. 1D and SI Appendix, Fig. S2B for
quantification). The level of ConA signal increases when the
worms are supplemented with glucose. Finally, we show that
supplementing Phsp-4:gfp(zcIs4) with 2-deoxyglucose (2DG), a
nonhydrolyzable glucose analog that can bring about transient
glucose restriction and is often used to initiate DR, leads to
increased expression of GFP that is suppressed by addition of
glucose (SI Appendix, Fig. S2C). Together, DR triggers a tran-
sient up-regulation of UPRER, possibly as a result of glucose
restriction.
Life Span Extension by DR Is Dependent on IRE-1. Knocking down
the eat-2 gene or implementing bacterial dilution-mediated di-
etary restriction (BDR) has been shown to decrease proteotox-
icity and enhance longevity in adult worms (36). Since in higher
eukaryotes, ER is responsible for folding a considerable part of
the proteome, we investigated the importance of the UPRER
machinery in proteoprotective, longevity benefits conferred by
DR. Toward this end, life span analysis was performed in 2 ge-
netic mimics of DR, in the presence or absence of ire-1, atf-6,
or pek-1, the ER membrane proteins that function to sense
misfolded protein stress. Interestingly, knocking down ire-1 led
to a significant suppression in life span of eat-2(ad1116) (Fig.
2A and SI Appendix, Table S1) while the life span extension by
drl-1 KD was completely abolished in an ire-1 mutant ire-1(v33)
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Fig. 2. Ire-1 is required for longevity assurance by DR and transient Tm supplementation. (A) Life span extension in eat-2(ad1116) mutant is suppressed on
knocking down ire-1. (B) Atf-6 knockdown has little effect on eat-2(ad1116) life span. (C) Pek-1 knockdown has no effect on life span extension in eat-
2(ad1116) mutant. (D) Transient supplementation of Tm during initial larval stage is sufficient to extend adult life span. WT worms were bleached and eggs
were added to M9 buffer containing bacterial feed and supplemented with 0.125 μg/mL Tm for the first 24 h and later scored for adult life span. As a control,
worms were treated with 0.05% DMSO (Tm = 0 μg/mL). (E) Tm-mediated increase in life span is dependent on ire-1. WT and ire-1(v33) mutants were sup-
plemented with Tm (0.125 μg/mL) for the initial 24 h and later scored for adult life span. (F) Tm supplementation cannot further increase life span of eat-
2(ad1116). Complete life span data are presented in SI Appendix, Table S1.
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(SI Appendix, Fig. S3A and Table S1). However, the other signal
sensors, i.e., pek-1 and atf-6 were found to be dispensable for both
the genetic paradigms of DR-mediated longevity (Fig. 2 B and C
and SI Appendix, Fig. S3 B and C and Table S1). It may be noted
that the RNAi interventions efficiently decreased transcript levels
of ire-1, atf-6, as well as pek-1 in WT and eat-2(ad1116) (SI Ap-
pendix, Fig. S3D). In order to enhance the RNAi efficiency in the
eat-2 mutant, the rrf-3 mutant background was used (37). These
data suggest that specific UPRER signaling through IRE-1 is re-
quired for eat-2 and drl-1 KD-mediated life span extension.
Early and Transient Up-Regulation of UPRER Is Sufficient for Life Span
Extension. Since we observed the transient up-regulation of
UPRER, we asked whether it plays a causal role in life span ex-
tension, as observed during DR. For this, we mimicked the
transient UPRER up-regulation using an external supplementa-
tion of a small dose of Tm for 24 h during hatching of the eggs in
liquid culture. After the drug was washed off, the worms were
grown on solid nematode growth media (NGM) and postadult
life span was recorded. Interestingly, we found that exposing WT
larvae to 0.125 μg/mL of Tm during the first 24 h of its post-
embryonic life led to significant extension of life span (Fig. 2D).
Similar to DR, this longevity effect was completely dependent on
ire-1 (Fig. 2E). This observation supports the role of hormesis,
triggered by an early ER stress as a mechanism of DR-mediated
life span enhancement, in the models that we tested. Impor-
tantly, pharmacological ER stress could not further extend the
life span of eat-2(ad1116) worms (Fig. 2F), suggesting that these
2 interventions use similar adaptive response to retard aging.
Additionally, transiently supplementing 2DG was also capable of
significantly increasing life span, in an ire-1–dependent manner
(SI Appendix, Fig. S3 E and F). These results suggest that a
hormetic dose of ER stress may be responsible for increased life
span observed during DR.
DR and a Hormetic Dose of ER Stress Delays the Age-Related Decline
in iUPRER Efficiency. The efficiency of the ER stress response de-
creases with age, resulting in a progressively dysfunctional ER.
Not only the levels of various UPRER target genes decrease in
old rats and mice, the efficiency of mounting UPRER in response
to various insults (iUPRER) also decreases with age (9, 38, 39).
We asked whether the iUPRER efficiency is maintained in the
genetic models of DR on different days of adulthood. As pre-
viously reported, we also observed a decline in iUPRER effi-
ciency on the second and third days of adulthood in WT worms,
respectively (Fig. 3A [dark blue bars], SI Appendix, Fig. 3 S4A
[dark green bars]). Importantly, this decline was significantly
delayed in DR worms as both eat-2(ad1116);Phsp-4:gfp as well as
Phsp-4:gfp worms grown on drl-1 RNAi displayed higher induc-
tions of GFP fluorescence following acute Tm treatment (Fig. 3A
[light blue bars] and SI Appendix, Fig. 3 S4A [light green bars]).
The DR worms also maintained low basal levels of UPRER sim-
ilar to that observed in daf-2(e1370) (40) (SI Appendix, Fig. S4 B
and C).
Since we observed that transient ER stress using Tm at early
postembryonic stage increased life span, we asked whether this
treatment could also lead to a better iUPRER efficiency with age.
Toward this end, we checked the iUPRER efficiency of transiently
Tm-treated worms on day 2 of adulthood and found that these
worms displayed higher iUPRER efficiency (Fig. 3B). These ob-
servations suggest that ER in DR worms are maintained in a
healthier state and are more potent in combating external stres-
sors even at a later age, when the WT ER efficiency typically
declines. Importantly, hormetic up-regulation of the ER stress
response during early developmental life leads to this increased
ER efficiency contributing toward enhanced longevity during DR.
DR Increases the Expression of Genes Responsible for Protein
Homeostasis within ER. Our data suggest that DR may help to
partly combat the proteostasis collapse that occurs within the
first 2 d of adult life (41), through a hormetic up-regulation of
UPRER during development. In an effort to better understand
this process during DR, we assessed the changes in the global
transcriptome profile of wild type and eat-2(ad1116) at day 1 of
adulthood (42, 43). We determined the Gene Ontology (GO) terms
and Kyoto Encyclopedia of Genes and Genomes (KEGG) path-
ways for the genes that were up-regulated >2-fold (P value ≤0.05)
in eat-2(ad1116)mutant as compared to WT and found that genes
associated with protein folding functions within the ER were sig-
nificantly enriched in this set (Fig. 4A). A total of 41 transcripts
comprising the proximal UPR sensors (ire-1, atf-6, and pek-1),
hsp-70 family members, J-domain proteins, and ERAD compo-
nents were up-regulated (SI Appendix, Table S2). Many of these
genes are well-known UPRER targets. These results suggested
that DR leads to a transcriptional reprogramming that supports
a more efficient ER.
We performed quantitative real-time PCR (QRT-PCR) anal-
ysis to validate our sequencing results. The mRNA levels of 5 of
the UPR target genes, sel-1, sel-11, ufd-2, pdr-1, and dnj-1, show
up-regulation in eat-2 mutant worms as compared to WT (Fig.
4B). This increase in expression starts early in development in
eat-2 mutant worms undergoing DR and is sustained until
adulthood (SI Appendix, Fig. S5A). Similarly, implementing DR
by knocking down drl-1 also led to a significant increase in the
mRNA level of these UPR target genes during adulthood, sug-
gesting conserved up-regulation of this pathway in different DR
paradigms (SI Appendix, Fig. S5B). We further identified that the
up-regulation of these UPR genes is dependent on the UPR
sensor ire-1, in both the eat-2 and drl-1 paradigms (SI Appendix,
Fig. S5 C and D).
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Fig. 3. DR delays age-associated reduction in iUPRER efficiency. (A) eat-
2(ad1116) mutants have delayed age-associated decline in iUPRER efficiency.
Representative images of Phsp-4:gfp and eat-2(ad1116);Phsp-4:gfp worms
with/without acute Tm treatment (10 μg/mL for 6 h) on different days of
adulthood. Graph represents normalized fold induction in GFP fluorescence
after 6 h of Tm treatment in WT and eat-2(ad1116) on different days of
adulthood, averaged over 3 biological repeats. (Normalization was per-
formed with the basal GFP fluorescence [basal UPRER] for individual exper-
iments). (B) Transient Tm supplementation increases iUPRER efficiency at day
2 of adulthood. Representative images of day 2 adult Phsp-4:gfp(zcIs4)
worms grown on control RNAi, treated with different concentrations of Tm
for 24 h after egg synchronization and further challenged with Tm (5 μg/mL
for 6 h) on day 2 of adulthood. Graph represents normalized fold induc-
tion in GFP fluorescence averaged over 2 biological repeats. Error bars are
SEM. * represents P < 0.05, Student’s t test.
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ERAD in DR Worms Efficiently Degrades ER Proteins. ERAD is an
adaptive mechanism of the ER that regulates protein homeo-
stasis within the organelle (44). It involves degradation of the
misfolded proteins so as to prevent their accumulation inside the
ER lumen. In the DR transcriptome mentioned above, genes
pertaining to the ERAD pathway formed almost half of the
enriched ER gene set (19 out of 41 up-regulated transcripts)
(Fig. 4C and SI Appendix, Table S2). This indicated that DR in
the 2 paradigms that we tested, may transcriptionally up-regulate
ERAD, possibly to maintain proteostasis within the organelle at
adulthood. To validate this, we performed a cycloheximide chase
assay in WT and eat-2(ad1116) worms on day 1 of adulthood to
probe the turnover kinetics of an ER resident protein (Fig. 4D).
Protein abundance at a particular time is a cumulative result of
active protein synthesis and degradation. Cycloheximide is a
protein synthesis inhibitor and supplementation of this drug
followed by Western blotting allows for specific reporting of the
rate of protein degradation. We compared the levels of HSP-4,
an ER resident protein, after cycloheximide treatment in WT
and eat-2 mutant and found a faster degradation of HSP-4 in DR
worms (Fig. 4D) that was abrogated on sel-1 knockdown using
RNAi (Fig. 4E). SEL-1 (ortholog of mammalian HRD3) is a vital
component of HRD-3/HRD-1 E3 ubiquitin ligase complex (44–
47). This indicates a more competent ERADmachinery operating
within DR worms as compared to their wild-type counterpart.
Proteins destined for degradation are affixed with a polyubiquitin
chain that serves as a degradation signal. Therefore, we assessed
the changes in ubiquitination profile of WT and DR worms, by
performing a Western blot using a polyubiquitin antibody. Con-
sistently with a robust ERAD, we observed higher ubiquitination
of proteins in eat-2(ad1116), suggesting that more proteins are
destined for degradation under DR (Fig. 4F). Better ERAD is
also indicative of a healthy ER that may contribute to the increase
in longevity of DR worms.
Life Span Extension by DR Is Dependent on ERAD Genes.As we found
evidence of an up-regulated ERAD during DR, we next asked
whether it is required for promoting increased longevity. We
performed life span analysis of WT and eat-2(ad1116) worms on
bacteria expressing RNAi against 2 of the up-regulated ERAD
genes, ufd-2 and sel-1. UFD-2 functions in complex with CDC48
to regulate the length of polyubiquitin chains attached to pro-
teins (44–47). We found that life span extension of eat-2(ad1116)
was partially suppressed on knocking down ufd-2 or sel-1 (Fig.
4G and SI Appendix, Table S1), supporting their important role
in DR-mediated longevity. The inability to observe a complete
repression of DR life span is possibly due to the existence of
different ERAD branches and redundancy in the functions
performed by them. Altogether, DR promotes a healthy ER that
can mount an effective ER stress response with age while effi-
ciently degrading ER resident proteins to maintain ER homeo-
stasis and increase life span.
FOXA Transcription Factor PHA-4 Controls Important Aspects of ER
Homeostasis. The C. elegans FOXA transcription factor PHA-4
is required for increased life span that is observed in multiple
genetic as well as nongenetic paradigms of DR (33, 43, 48, 49).
Hence, we asked whether up-regulation of the ER protein pro-
cessing genes in an eat-2 mutant worm is dependent on PHA-4.
Using metadata analysis of published PHA-4 ChIP-seq data (43,
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50), we found that PHA-4 binds to the promoter proximal sites
of all of the 5 ER protein processing genes that are up-regulated
in eat-2(ad1116) (Fig. 5A). QRT-PCR analysis showed that
knocking down pha-4 significantly suppressed the induction of
these genes in eat-2(ad1116) at young adult stage (Fig. 5B). This
suggests that DR transcriptionally up-regulates genes that
maintain protein folding homeostasis in the ER during early
adulthood, in a manner dependent on ER sensor ire-1 and DR-
specific FOXA transcription factor PHA-4.
Next, we asked whether PHA-4/FOXA is involved in any other
aspect of ER homeostasis. For that, we knocked down pha-4
using RNAi is hsp-4::gfp or eat-2(ad1116)::hsp-4::gfp and mea-
sured the transient up-regulation of ER stress early during de-
velopment as seen in the genetic paradigms of DR. We found
that the eat-2(ad1116) worms lose the capability to mount the
transient response at L2 stage when pha-4 is knocked down
(Fig. 5C), while there was no effect of pha-4 RNAi on hsp-4::gfp in
WT background. Next, we asked whether PHA-4 regulates the
iUPRER at adulthood when the worms are preconditioned at
L2 with a hormetic dose of ER stress using Tm. Intriguingly, in
absence of preconditioning, the adult pha-4 knockdown worms
mounted an iUPRER (on acute 5 mg/mL tunicamycin treatment)
(Fig. 5D; compare panels under 0 μg/mL column) that was much
higher than the control RNAi worms. On the other hand, while
the control RNAi worms mounted an even higher iUPRER when
given Tm hormesis (compare panels in control RNAi row), pha-4
RNAi worms were not able to increase the iUPRER response,
suggesting that the process is deregulated in absence of PHA-4.
Consequently, knocking down PHA-4 suppressed the Tm hormesis-
mediated life span extension (Fig. 5E; compare panels in control
RNAi). Coupled to many other DR-specific functions of PHA-4,
these observations justify the important role of this transcription
factor in DR-mediated life span extension.
DR Alleviates Polyglutamine Aggregation in an ire-1- and ERAD-
Dependent Manner. In the context of protein homeostasis, a bet-
ter health span will translate into fewer deleterious proteins
accumulating or aggregating within the cell. Proteins that carry a
stretch of polyglutamine residue over a threshold length are
known to aggregate with age. These form the basis for various
polyglutamine expansion disorders like Huntington’s and spi-
nocerebellar ataxias (51). The exposed hydrophobic patches
formed by multiple glutamine residues, typically more than 35,
increases the chances of protein aggregation. Inefficient degra-
dation of these proteins with increasing age exacerbates aggre-
gation and associated diseases (52, 53). Supporting this is the
observation that impaired ERAD and ER stress are primary
events that augment polyglutamine toxicity (54). C. elegans is
used as a model organism to study polyglutamine aggregation
owing to the availability of fluorescent reporters that help in
visualizing aggregate formation in different tissues, in real time.
In order to evaluate the role of DR in augmenting the ERAD
and its physiological consequences, we used a reporter that ex-
presses a stretch of 40 glutamines (Q40) tagged with a yellow
fluorescent protein in C. elegans muscle (55). We crossed this
reporter strain with eat-2(ad1116) to generate mutant worms car-
rying both the reporter transgene and the eat-2mutation [hereafter,
referred to as eat-2(−);polyQ]. We observed that incorporating
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body. (Lower) Input DNA. Light blue bars represent a portion of the gene of interest. (B) QRT-PCR analysis was used to compare ER protein processing genes
between eat-2(ad1116) and WT adults grown on control or pha-4 RNAi. Graph shows significant suppression of the up-regulated genes on pha-4 knockdown.
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17388 | www.pnas.org/cgi/doi/10.1073/pnas.1900055116 Matai et al.
eat-2 mutation led to 50 to 70% suppression in the number of
aggregates at all age points, supporting the earlier observation of
alleviation in the age-associated increase in polyQ aggregation
during DR (Fig. 6A) (36). Additionally, the SDS-soluble form of
polyQ protein was more in eat-2 mutant worms compared to WT,
suggesting that partitioning of polyQ into SDS-insoluble aggre-
gates decreased in eat-2 worms (SI Appendix, Fig. S6A). This may
exclude the possibility that lower level of polyQ expression in eat-2
mutants led to decrease in puncta numbers. Knocking down drl-1
also decreased the number of aggregates observed in the reporter
worm with age, suggesting a conserved phenomenon of DR-mediated
reduction in aggregation (SI Appendix, Fig. S6B). Since ire-1 was
a requirement for DR-mediated longevity, we therefore asked
whether this beneficial effect conferred by DR is also dependent
on this gene. We observed that the decrease in polyQ aggrega-
tion observed in eat-2 mutant worms was abrogated on ire-1
knockdown (Fig. 6A). Supporting this was the observation that
SDS-soluble polyQ protein decreased in the eat-2(ad1116) with
ire-1 RNAi knockdown (SI Appendix, Fig. S6A). Similarly, ire-1
mutants failed to suppress the number of polyQ aggregates on
drl-1 knockdown at different days of adulthood, suggesting a
dependence on ire-1 branch of UPRER for maintenance of pro-
teostasis (SI Appendix, Fig. S6B). It may be noted that the puncta
numbers increased in wild type when ire-1 is knocked down or
mutated, showing its role in proteostasis.
Finally, to further evaluate the role of ERAD machinery in
DR-induced suppression of polyglutamine aggregation, eat-2(-);
polyQ worms were grown on control, ufd-2, or sel-1 RNAi. We
A DR ameliorates PolyQ aggregation in an ire-1 dependent manner 
B DR ameliorates PolyQ aggregation in an ERAD dependent manner 
C Transient Tm supplementation ameliorates PolyQ
aggregation
0
0.1
25
0.2
5 0.5
0
5
10
15
20
Tm supplementation
Day 1
Day 2
Day 3* ** *
D Reduced aggregation of PolyQ on transient 
treatment with Tunicamycin   
E Enhanced degradation of PolyQ on transient 
treatment with Tunicamycin 
A
ve
ra
ge
 P
un
ct
a 
nu
m
be
r
0 10 20 30 40
polyQ Control RNAi
eat-2(-);polyQ Control RNAi
polyQ ufd-2 RNAi
eat-2(-);polyQ ufd-2 RNAi
polyQ sel-1 RNAi
eat-2(-);polyQ sel-1 RNAi
Average Puncta number
70%
59%
44%
51%
27%
10%
49%
19%
10% ns
ns
*
ns
ns
*
ns
**
**
D
ay
 1
D
ay
 2
D
ay
 3
during development (µg/ml)
Av
er
ag
e 
pu
nc
ta
nu
m
be
r
1 2 3
Day
0
10
20
40
30 *
*
*
48%
31%
51%
70%
49%
32%
*
**
**
Fig. 6. Suppression of polyQ aggregation with age in DR is dependent on ire-1 and ERAD. (A) Representative images showing polyQ aggregates in Punc-
54:polyQ40:yfp and eat-2(ad1116);Punc-54:polyQ40:yfp worms on control or ire-1 RNAi at day 2 of adulthood. Suppression of polyQ aggregation in eat-2
mutants is partly abrogated on knocking down ire-1. Average puncta number per worm from 3 biological replicates is plotted. Error bars show SD. (B)
Representative images showing polyQ aggregates for Punc-54:polyQ40:yfp and eat-2(ad1116);Punc-54:polyQ40:yfp worms on control RNAi or RNAi against
ERAD genes (ufd-2 or sel-1) at day 2 of adulthood. Suppression of polyQ aggregation in eat-2 mutants is partially abrogated on knocking down ufd-2 and sel-1.
Average of 3 biological replicates is plotted. Error bars show SD. (C ) PolyQ aggregates in Punc-54:polyQ40:yfp worms on control RNAi that have been
exposed to different concentrations of Tm during early larval development. Graph represents number of aggregates in Punc-54:polyQ40:yfp worms on
different days of adulthood. Worms exposed to 0.125 μg/mL and 0.25 μg/mL Tm during larval development show significant reduction in the number of
aggregates on day 2 and day 3. Average of 3 biological replicates is plotted. Error bars show SEM. Representative images shown in SI Appendix, Fig. S6C. *P <
0.05, **P < 0.01 as determined by Student’s t test; ns, nonsignificant. (D) HD150Q cells were pretreated with tunicamycin for 5 h, washed, and then incubated
with Pon A for 24 h (which was then washed off) to induce the expression of mutant huntingtin-GFP. At 36 h postinduction, cells were observed under
fluorescence microscope to assess the formation of mutant huntingtin aggregates. Representative images are presented in SI Appendix, Fig. S7A. (E ) Cells
were treated as above and after washing off Pon A, chased following cycloheximide treatment for different time periods. The lysates were subjected
to immunoblot analysis of mutant huntingtin-GFP using GFP antibody. Data were normalized with β-actin. Values are mean ± SEM of 3 independent
experiments.
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found that eat-2(ad1116) worms grown on ERAD gene RNAi had
less suppression of polyQ puncta (Fig. 6B) and a lesser level of
SDS-soluble polyQ protein (SI Appendix, Fig. S6A) compared to
control RNAi-grown worms. This suggests that DR leads to a
healthier ER that reduces polyglutamine aggregation in adult
worms in a manner dependent on ire-1 and ERAD. It may be
noted that the suppression of aggregation is not complete either
due to the efficiency of the RNAi or due to redundant pathways
that may be involved.
A Hormetic Dose of ER Stress, during Early Life, Suppresses polyQ
Aggregation. We reported that an atypical up-regulation of
UPRER in larvae contributes toward increased life span during
DR. We showed that pharmaceutically mimicking the transient
UPRER up-regulation during early larval life augmented the
iUPRER efficiency with age and increased life span. To de-
termine whether such hormetic intervention can protect against
age-related proteostasis collapse, we exposed WT worms with a
range of concentrations to Tm only during the start of larval
development, as mentioned before. We compared the untreated
and Tm-treated polyQ worms for the number of aggregates on
different days of adulthood and witnessed a suppression in the
treated worms (Fig. 6C and SI Appendix, Fig. S6C). Moreover,
this phenomenon was also found to be dependent on the proximal
UPR sensor ire-1, as in ire-1(v33);Q40:yfp worms treated with a
hormetic dose of Tm, no reduction in puncta was observed (SI
Appendix, Fig. S6D). Together these observations suggest that DR
triggers ER hormesis to improve proteostasis and ameliorate
polyglutamine aggregation during adult life and extend longevity.
A Hormetic Dose of ER Stress Is Able to Improve Proteostasis in
Mammalian Cells. Since a hormetic dose of ER stress has bene-
ficial effects in worms in terms of better proteostasis, we next
asked whether such an intervention will be beneficial in a
mammalian model of protein aggregation. For this, we used an
inducible cell line system that overexpresses polyglutamine using
ponasterone A (Pon A) (56). The cells were pretreated with
0.125 or 0.25 μg/mL of Tm for 5 h, washed and induced with Pon
A for 36 h. We find that pretreatment with Tm leads to signifi-
cant abrogation of polyQ150 aggregation (Fig. 6D and SI Ap-
pendix, Fig. S7A). Western blot analysis revealed that Tm
pretreatment leads to decreased levels of polyQ150 but in-
creased levels of ER-localized HSP70 (SI Appendix, Fig. S7B).
Levels of IRE-1α and several ER chaperones as well as apoptotic
marker CHOP were up-regulated by Tm pretreatment, suggest-
ing that the UPRER is up-regulated (SI Appendix, Fig. S7C).
Cycloheximide chase experiment showed that the polyQ is de-
graded faster on Tm pretreatment (Fig. 6E). Finally, the Tm
preconditioning led to higher viability of the polyQ150-expressing
cells on day 5 post-Pon A induction, as determined by 3-(4,5-di-
methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay
(SI Appendix, Fig. S7D). Together, these experiments show that
Tm hormesis may also provide beneficial effects in a mammalian
model of protein aggregation, similar to worms, although the
molecular mechanisms need to be elucidated.
Discussion
Proteostasis collapse has long been associated with incidences of
various diseases of protein aggregation. The catastrophic col-
lapse of cellular proteostasis marks the commencement of the
aging process (8). Thus, interventions that can delay the onset of
the collapse has positive effects on health and longevity. Here, we
show that DR effectively delays proteostasis collapse by main-
taining robust iUPRER and ERAD during adulthood, leading to
increased life span. This is partially mediated by a sublethal dose
of ER stress early during development that primes the ER for
better function later in life. We also show that the mechanism
maybe conserved in a mammalian cell culture model of protein
aggregation. Since a sublethal ER stress generated by DR is able
to confer health and life span benefits at adulthood, this mecha-
nism may be categorized as hormesis.
DR has long been argued as a case of hormesis (57–59). While
DR confers health and life span benefits, extended periods of DR
or starvation may be detrimental (58). Even in C. elegans, BDR
produces a typical bell-shaped curve with ad libitum and lowest
dilution-fed worms showing no life span benefits (48, 60). In-
cidentally, the mechanisms of hormesis in case of DRmostly point
toward mitochondrial metabolism. Glucose restriction, another
mode of DR that also increases life span, works through a pro-
cess of mitohormesis involving ROS-mediated up-regulation
of cellular detoxification machinery (20). Additionally, lowering
insulin-IGF1 signaling that is akin to reduced glucose metabo-
lism requires mitohormesis to increase life span (21). Although,
IRE-1 was found to be involved in life span regulation during
DR, the mechanism was not linked to ER hormesis (61). Our
study now elucidates how ER hormesis functions during DR,
adding to the list of known mechanisms by which the conserved
life span-extending intervention of diet restriction works.
DR can be implemented in a variety of ways. Classically, in the
widely used C. elegans genetic model (eat-2) and the relatively
newer paradigm (drl-1), DR is initiated at hatching; these para-
digms may be termed developmental DR. On the contrary,
nongenetic methods of DR are usually implemented during
adulthood. As the C. elegans in culture gets ad libitum access to
food, unlike in the wild, genetic DR paradigms may actually
represent optimum nutrition to the organism from early devel-
opment. Rapid cell division and active metabolism during the
early growth period may be sensitive to the developmental DR
regime due to glucose restriction. This may result in the transient
ER stress that we observed in the genetic models of DR. This
assumption is supported by the fact that glycosylated proteins are
fewer during DR and supplementation of glucose abrogates the
transient ER stress (this study) as well as reduces life span (62,
63). We also show that a nonhydrolyzable form of glucose in-
duces ER stress early in life that is suppressed by glucose sup-
plementation. This transient intervention also increases life span.
Since glucose restriction is known to alter mitochondrial dy-
namics, it will be interesting to study whether mitochondria may
have a role to play in ER hormesis during DR.
We show that exposing worms to an early transient ER stress
is able to increase life span and improve proteostasis in adult-
hood by the process of ER hormesis. It appears that a cellular
memory is created by the sublethal ER stress during develop-
ment that helps maintain a prolongevity transcriptional status. In
support of this, we observe that the expression of the ERAD genes
are increased early in the eat-2mutant worms and maintained into
adulthood, even when the basal ER stress is low during DR. In
future, the nature of the memory needs to be deciphered. It is
possible that the memory is at the level of chromatin and tran-
scription, involving DNA or histone modifications. Indeed, in the
case of mitohormesis involving C. elegans mitochondrial dysfunc-
tion (64, 65), histone lysine methylases like jmjd-1.2 and jmjd-3.2
are essential (66). This assumption is also supported by observa-
tions where DR has been shown to affect chromatin modifications
(67) and that ER stress can modify the epigenome (68).
We have shown here that DR as well ER hormesis prevents
decline of iUPRER efficiency that occurs with age. We observe
that the basal ER stress levels are lower and that the organism can
mount a robust iUPRER when challenged. The basal ER stress
levels were also found to be lower in an insulin-IGF1 signaling
mutant (40). We have shown earlier that ROS generated due to
protein misfolding stress is responsible for attenuation of induced
UPRER in yeast and C. elegans (34). It is possible that lower levels
of ROS that is generated in eat-2 and daf-2 mutants due to in-
creased levels of ROS detoxification system genes may help the
system to maintain a poised ER (33, 34, 40, 48, 69, 70).
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The FOXA transcription factor PHA-4 plays a central role in
DR-mediated longevity in C. elegans. It appears that the PHA-
4 controls many prolongevity aspects of DR. PHA-4 has been
shown to control the expression of the majority of the mRNAs as
well as miRNAs up-regulated during DR (42, 43). It transcrip-
tionally regulates the expression of genes coding for chromatin
modifiers required for modulation of gene expression (49), xe-
nobiotic detoxification pathway components (33), the superoxide
dismutase system (48), as well as those involved in the splic-
ing and nonsense-mediated decay pathway (43). In this study,
we show that PHA-4 regulates the expression of the ERAD
component genes, the transient UPRER at L2, as well as
modulates iUPRER at adulthood. These finding show that the
transcription factor controls diverse aspects of the regulatory
network that provides prolongevity benefits of DR, qualifying
as the central regulator of this process.
In conclusion, our study provides insights into the various cellular
mechanisms used by DR to increase health and life span, showing
the role of ER hormesis in maintaining proteostasis in adulthood.
Materials and Methods
Detailed experimental procedures are provided in SI Appendix. Unless oth-
erwise mentioned, all of the C. elegans strains were maintained and propa-
gated at 20 °C on Escherichia coli OP50 using standard procedures (71). For life
span assays, 50 to 60 young adult worms grown on RNAi bacteria since
hatching were transferred to similar RNAi plates in triplicates and overlaid
with fluorodeoxyuridine (FudR) to a final concentration of 0.1 mg/mL of agar
(72). After day 7 of adulthood, when all sick, sluggish, and slow dwelling
worms were removed, numbers of dead worms were scored every alternate
day and plotted as % survival against the number of days. Statistical analysis
for survival was conducted using Mantel–Cox log rank test using Oasis soft-
ware available at http://sbi.postech.ac.kr/oasis. For measurement of basal
UPRER during larval development, Phsp-4:gfp(zcIs4) and eat-2(ad1116);Phsp-
4:gfp(zcIs4) eggs were hatched on control RNAi. Fifty L3, L4, young adult or
day 1 gravid adult worms were immobilized on glass slides coated with 2%
agarose using 20 mM sodium azide and visualized under an Axio-imager
M2 epifluorescent microscope (Carl Zeiss, Germany) equipped with a mono-
chromatic camera lens (MRm) and GFP filter set. Fluorescence of 20 worms at
different time points was quantified using NIH ImageJ software and repre-
sented as arbitrary units (AU). For measurement of induced UPRER efficiency,
worms were allowed to grow as above until adulthood and then transferred
onto plates overlaid with FuDR to a final concentration of 0.1 mg/mL. At each
successive day (day 1 until day 3 of adulthood), ∼100 worms were transferred
to plates supplemented with 5 or 10 μg/mL Tm and incubated for 6 h at 20 °C.
After 6 h, worms were visualize as above. Average fluorescence of treated
worms was normalized to untreated worms and plotted as normalized GFP-
fold induction at different days of adulthood. For Tm hormesis treatment,
eggs were resuspended in 100 to 200 μL of 1× M9 buffer and treated with
0.125 μg/mL (see SI Appendix for details of media preparation). Eggs were left
on rotation in the Tm-bacteria mixture at a slow speed for 24 h. Following this,
the hatched L1 larvae were washed 3 to 4 times with 1×M9 buffer to remove
traces of Tm and added onto seeded control RNAi plates containing no drug.
They were allowed to grow until adulthood when 100 worms belonging to
each treatment regime were transferred onto FuDR containing RNAi plates,
and life span was scored as mentioned above.
For RNA-seq analysis, synchronized day 1 gravid worms [WT and eat-
2(ad1116)] grown on E. coli OP50 were collected using M9 buffer after
washing thrice to remove bacteria. Total RNA was isolated from these worm
pellets using the TRIzol method. A RNA-seq library was subsequently con-
structed by TruSeq RNA Library Prep Kit v2 (Illumina) and sequencing was
performed using the Illumina Genome Analyzer. The RNA-seq data are
available at the National Center for Biotechnology Information (NCBI) with
the BioProject ID PRJNA342407 (42, 43). For the cycloheximide chase ex-
periments, day 1 adult WT and eat-2(ad1116) worms grown on control RNAi
were washed from plates to remove adhered bacteria and added to 1× S-
basal buffer containing 2 mg/mL cycloheximide (Sigma-Aldrich). The exper-
iment was performed in 24-well plates with each well containing 500 μL of
drug-buffer solution with gentle agitation. At each time point, including at
0 h, worms were washed thrice with 1 ×M9 buffer to remove traces of cy-
cloheximide and resuspended in 100 μL of 5% Triton X-100 solution con-
taining 1×-EDTA free protease inhibitor mixture (Sigma-Aldrich). Cell lysates,
prepared from these samples, were run on a denaturing SDS/PAGE, and
HSP-4 levels were detected at each time point by Western blot analysis.
Ubiquitination assay was performed on day 1 adult WT (Bristol N2) or
eat-2(ad1116) worms grown on control RNAi. The worms were washed to
remove adherent bacteria and added to 1× S-basal buffer with or without
100 μM of MG-132, a proteasomal inhibitor. The worms were incubated in
these solutions in 24-well plates for 6 h at 20 °C with gentle shaking. They
were later washed thrice to remove traces of MG-132. The worm pellets
were then resuspended in 100 μL of 5% Triton X-100 solution containing 1×
EDTA-free protease inhibitor mixture (Sigma-Aldrich). Cell lysates, prepared
from these samples were run on denaturing SDS/PAGE and blotted using a
polyubiquitin antibody (catalog no. BML-PW8810; Enzo Lifesciences). For
aggregation assay, the polyQ reporter strain was crossed with ire-1(v33) and
eat-2(ad1116)mutants to assess the polyQ aggregation profile in these mutants
as compared to WT. All of the strains were grown on control or test-RNAi until
adulthood and then transferred onto RNAi plates overlaid with FuDR to
a final concentration of 0.1 mg/mL. At each successive day from day 1 until
day 3 of adulthood, 25 worms of each strain (grown on a particular RNAi)
were mounted onto 2% agarose slides and visualized using an Axio-Imager
M2 epifluorescent microscope using the YFP filter set. Total number of bright
spots (puncta or aggregates) on the worm body wall were counted and av-
erage number of aggregates for >20 worms was plotted. For cell culture ex-
periments, HD150Q cells were cultured in DMEMwith 10% FBS and antibiotics
containing 0.4 mg/mL zeocin and 0.4 mg/mL G418 (geneticin). During experi-
ments, cells were plated onto 6-well tissue culture plates at subconfluent
density and on the following day, they were treated with different concen-
trations of tunicamycin (0.125 and 0.250 μg/mL) for 5 h, washed, and then
treated with ponasterone A (1 μM) to induce the expression of mutant hun-
tingtin. After 36 h of ponasterone A treatment, cells were observed under
fluorescence microscope followed by collection and processing of the cells for
immunoblotting experiments. Aggregate formation was manually counted
under a fluorescence microscope (∼500 cells in each group) and the cells con-
taining more than one aggregate were considered to have a single aggregate.
MTT assay was used to evaluate the viability of the cells on Tm hormesis.
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